Seminars in Hematology
Volume 45 , Pages S17-S21 , July 2008

Targeting FLT3 for the Treatment of Leukemia

  • Donald Small

      Affiliations

    • Corresponding Author InformationAddress correspondence to Donald Small, MD, PhD, Kyle Haydock Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center, CRB1-251, 1650 Orleans St, The Johns Hopkins University, Baltimore, MD 21231

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Research support/Principal Investigator: Imclone Systems, Ambit Biosciences, Xanthus Pharmaceuticals.

PII: S0037-1963(08)00123-6

doi: 10.1053/j.seminhematol.2008.07.007

Seminars in Hematology
Volume 45 , Pages S17-S21 , July 2008

Article Tools

* Image Usage & Resolution